PRP for Erectile Dysfunction: What the Studies Actually Show

By Dr. Farhan Abdullah, DO | Medical Director, Magnolia Functional Wellness | Southlake, TX

A patient sat across from me last month and said something I hear constantly, just phrased a little differently each time. "The pills work. I just don't want to take a pill for the rest of my life." He was 54, healthy enough, running his own business, and tired of planning intimacy around a prescription. What he wanted wasn't a better pill. He wanted the underlying problem fixed.

That's the conversation that leads most men to ask me about platelet-rich plasma. PRP for erectile dysfunction has gotten a lot of attention over the last several years, some of it earned and some of it wildly overstated by clinics that should know better. So let's do what I try to do with every patient at Magnolia Functional Wellness here in Southlake: separate the biology from the billboard.

I'm an internal medicine physician. I still round in the hospital. I've spent a long time watching what happens when men ignore vascular disease, and I've also spent enough time in regenerative medicine to know that the field has a marketing problem. Both of those things shape how I answer this question.

What PRP Actually Is (And What It Isn't)

Platelet-rich plasma is exactly what the name suggests. We draw your blood, spin it in a centrifuge, and concentrate the platelet fraction. Platelets aren't just clotting cells. They're storage containers packed with growth factors: vascular endothelial growth factor, platelet-derived growth factor, transforming growth factor beta, insulin-like growth factor, and dozens of signaling molecules that coordinate tissue repair.

When you concentrate those platelets and place them into damaged tissue, you're essentially delivering a repair signal at a dose the body wouldn't generate on its own. That's the whole premise. It's your biology, amplified and relocated.

Here's what PRP is not. It's not a stem cell treatment, though plenty of clinics blur that line in their advertising. It's not FDA-approved for erectile dysfunction. It's not going to fix a hormonal problem, a medication side effect, or a relationship that's under strain. And it's not a one-and-done cure that eliminates the need for everything else you should be doing for your cardiovascular health.

What it might be, for the right man, is a way to improve the actual tissue quality of the penis rather than just forcing a temporary response out of tissue that's already compromised.

Why Blood Flow Is the Real Story Behind Most ED

Something I wish more men understood: erectile dysfunction is usually a vascular diagnosis before it's a sexual one. The penis runs on small arteries. Small arteries clog before big ones do. Which means ED frequently shows up three to five years before a cardiac event, and I mean that literally. When a 48-year-old tells me his erections have gotten softer over the past year, my brain doesn't go straight to sexual medicine. It goes to endothelial function, lipids, insulin resistance, blood pressure, and sleep apnea.

That's why I don't love the way ED gets treated in a lot of settings. A quick telehealth visit, a prescription for tadalafil, no labs, no exam, no conversation. PDE5 inhibitors are genuinely useful drugs and I prescribe them often at Magnolia. But they work downstream. They amplify a signal in tissue that may already be scarred, fibrotic, and poorly perfused. They don't change the tissue itself.

The regenerative argument for PRP is that it works upstream. Growth factors like VEGF promote angiogenesis, the formation of new small blood vessels. Others appear to reduce fibrosis in the corpora cavernosa, which is the smooth-muscle-rich erectile tissue that fills with blood. In animal models, especially diabetic rat models where the vascular damage is severe and consistent, intracavernosal PRP has repeatedly improved measurable erectile parameters and increased smooth muscle content. That's a real mechanistic signal, not a marketing claim.

Animal data is where a lot of promising therapies go to die, though. So what happened when this reached humans?

What the Studies Actually Show

The trial that changed the conversation came out of Aristotle University of Thessaloniki. In 2021, Poulios and colleagues published the first double-blind, randomized, placebo-controlled trial of PRP for erectile dysfunction in the Journal of Sexual Medicine. Sixty men with mild to moderate ED received two sessions of either 10 mL intracavernosal PRP or placebo, one month apart, and were followed for six months.

At six months, 69 percent of the PRP group had achieved a minimal clinically important difference in their IIEF erectile function score, compared with 27 percent of the placebo group. The adjusted between-group difference was 3.9 points on the IIEF-EF scale. No adverse events were reported. For a first-in-humans randomized trial, that's a meaningful result.

But sixty men at one center is a starting point, not a verdict. So the field did what it should do next, which is aggregate.

In 2024, Mao and colleagues published a systematic review and meta-analysis in The Aging Male pooling four randomized controlled trials and 413 patients. PRP outperformed placebo on achieving that clinically important difference at both one month and six months. The effect was real but modest, and the authors were appropriately cautious about how few trials existed.

Then in 2025, Zhou and colleagues published a larger meta-analysis of seven randomized controlled trials covering 660 patients, also in The Aging Male. Here's where it gets interesting. IIEF scores improved significantly in the PRP group at 12 weeks and 24 weeks, but not at four weeks. Peak systolic velocity, which is an objective ultrasound measure of penile arterial blood flow rather than a questionnaire, improved substantially more in the PRP group. And the subgroup analysis found that adding PRP to low-intensity shockwave therapy produced considerably better IIEF scores than shockwave alone.

Read those results carefully and a pattern shows up. PRP doesn't work fast. It works slowly, over months, in a way that's consistent with actual tissue remodeling rather than a temporary pharmacologic effect. That timeline frustrates patients who expect a same-week result. It also happens to be exactly what you'd predict if the mechanism is genuine.

The honest limitations: sample sizes are still small, follow-up rarely extends past six to twelve months, PRP preparation protocols vary enormously between studies, and the placebo response in sexual medicine is notoriously large. Anyone who tells you the evidence is settled is selling something. Anyone who tells you there's no evidence hasn't read the literature.

Who Actually Benefits, and Who Doesn't

This is the part most clinic websites skip, and it's the part that matters most.

The men who tend to do well with PRP in my experience have mild to moderate ED, reasonably intact vascular health, and a partial response to PDE5 inhibitors. They're often in their 40s and 50s, noticing gradual decline rather than sudden failure. They want to reduce medication dependence rather than eliminate an impossible problem.

The men who tend not to do well are the ones with severe ED, poorly controlled diabetes, significant peripheral vascular disease, or a history of radical prostatectomy with nerve damage. That doesn't mean regenerative options are worthless for them. It means expectations need to be calibrated honestly, and PRP alone is unlikely to be the answer.

There's also a group I see constantly that gets missed entirely: men whose ED is primarily hormonal or metabolic. If your total testosterone is 240 and your free testosterone is in the basement, injecting PRP into the penis is treating the wrong organ. If you've gained forty pounds in three years and your fasting insulin is climbing, the vascular damage is ongoing and PRP is trying to repair a building while someone's still knocking down walls. I've had patients whose erectile function normalized on hormone optimization and metabolic work alone, without a single injection.

That's why I won't do a PRP procedure for sexual health without labs first. Total and free testosterone, estradiol, SHBG, LH, prolactin, comprehensive metabolic panel, lipids, hemoglobin A1c, and thyroid. Sometimes the labs tell us PRP is a reasonable next step. Sometimes they tell us to fix something else first. Both outcomes are wins.

Combining Therapies: Where the Data Is Most Encouraging

The subgroup finding from the Zhou meta-analysis deserves more attention than it's gotten. PRP plus low-intensity shockwave therapy outperformed shockwave alone by a meaningful margin.

Mechanistically that tracks. Acoustic wave therapy creates controlled mechanical stress in tissue, which upregulates growth factor receptors and recruits resident progenitor cells. PRP delivers the growth factors. One prepares the soil, the other plants the seed. Using them together isn't just stacking treatments to raise the invoice. There's a plausible biological rationale and now some clinical signal behind it.

In my practice, the combination protocol is what I recommend most often for appropriate candidates. Usually a series of shockwave sessions with PRP layered in, alongside whatever hormonal or metabolic correction the labs called for. It's less dramatic than the single-miracle-injection story, and it works better.

What the Experience Is Actually Like

Men are far more anxious about this procedure than they need to be, and I understand why. The words "injection" and "penis" in the same sentence tend to end the conversation early.

Practically, it goes like this. We draw blood, usually 30 to 60 mL. It spins for about ten to fifteen minutes while a topical anesthetic works. We then use a very fine needle and local anesthetic before placing the PRP. Most men describe pressure more than pain. The whole visit runs under an hour, and you drive yourself home and go back to work.

Side effects are typically limited to mild bruising or temporary swelling. In the randomized trial data, adverse events were minimal. That safety profile is one of the genuine advantages of PRP, since you're being injected with a concentrate of your own blood rather than a foreign compound.

Results take time. Expect little at four weeks, something noticeable around eight to twelve weeks, and the fuller picture around six months. Most protocols involve two to three sessions spaced roughly a month apart. Anyone promising results in a week either hasn't read the studies or is counting on you not to.

The Bottom Line

PRP for erectile dysfunction sits in an honest middle ground, and I think that's fine. It has a plausible mechanism, supportive animal data, several randomized controlled trials showing modest but real benefit, and a strong safety record. It also has small sample sizes, short follow-up, inconsistent protocols, and no FDA approval for this indication. Both halves of that sentence are true.

What I tell my patients in Southlake is this: PRP is a reasonable option if you've done the foundational work first. Get your labs. Fix your hormones if they're broken. Address the metabolic drivers. Treat the sleep apnea. Move your body. Then, if you still want to improve the tissue itself rather than just work around it, PRP is a legitimate tool with real evidence behind it.

And if a man tells me his erections have changed, I'm going to talk to him about his heart too. Not to alarm him, but because those small vessels are telling us something about the big ones. Sexual health and cardiovascular health aren't separate conversations. They never were. At Magnolia Functional Wellness, that's the whole reason we look at the labs before we reach for the syringe.